… Most COVID-19 vaccines are designed to elicit immune … disease severity can occur 19 ,
and vaccine-induced immune selection … Vaccines for COVID-19 must therefore continue to be …

… a similar vaccine, complemented by the infusion of antigen-specific T cells. While both of
these vaccines are tested therapeutically in COVID-19 patients, most other vaccines are tested …

… The rollout of the COVID-19 vaccines brings hope that we can put an end to the pandemic.
At the moment of writing, there are four vaccines authorized in the European Union: two …

… COVID-19 vaccine has various advantages and disadvantages over the others, accessibility
and affordability of approved vaccines … data on available COVID-19 vaccines developed in …

… also been reported following COVID-19 mRNA vaccination, although no association …
mechanisms through which thrombotic phenomena may arise after adenoviral vector vaccination…

… of COVID-19 vaccines and tried to present the latest reports on the effectiveness of these
vaccines. … Several DNA vaccines against COVID-19 are currently in various clinical trials stages …

… The main finding in the present study was that AZ vaccination against COVID-19 induced a
… vaccination. Also, post-vaccination thrombin generation was higher for all parameters in AZ …

… COVID-19 and cancer, followed by a vaccine … the COVID-19 vaccine formulation options.
This study will contribute to paving the way towards the prevention and treatment of COVID-19, …

… Based on the mechanism by which a vaccine protects an individual against COVID-19
infection, it has been found that the already rolled out vaccines are mRNA (Pfizer and Moderna) …

… More in‐depth research is needed to substantiate such a ready‐to‐go mechanism; that
being said, here I propose the following: a single vaccine dose contains 5 × 10 10 adenoviral …